Treatment Guidelines
ACR/VF Treatment Guidelines
These guidelines present the first recommendations endorsed by the American College of Rheumatology (ACR) and the Vasculitis Foundation (VF) for the treatment and management of many types of vasculitis. The guidelines address remission induction and remission maintenance, treatments for specific organs and tissues damaged by vasculitis inflammation, and diagnostic strategies.
KDIGO 2024 aav GUIDELINES
These guidelines from Kidney Disease Improving Global Outcomes (KDIGO) provide updated recommendations and practice points on glucocorticoids, rituximab and complement inhibition to treat ANCA-associated vasculitis (AAV). The guidelines address the use of avacopan as an alternative to glucocorticoids, and plasma exchange for use in patients with advanced kidney disease.
eular 2022 AAV Guidelines
These recommendations from the European Alliance of Assocations for Rheumatology (EULAR) address the diagnosis and treatment of adult patients with ANCA-associated vasculitis (AAV) and are intended to give advice to clinicians, other health professionals, pharmaceutical companies and regulatory organisations.
British Society for Rheumatology AAV Guidelines
Management recommendations for physicians treating ANCA-associated vasculitis in people of all ages.
Published 12, June 2025
Thank you to our sponsors:
